Clinical biochemists have led the way in the application of quality control in the diagnostic services ever since the introduction of the first schemes in the early 1960s. With the possible exception of pharmacy departments, the clinical chemistry laboratories represent the largest source of expertise on this subject in the NHS.
The overall and continuing effect of the introduction and development of quality control procedures has been to improve the performance of each analytical technique up to the 'wall' which exists for each method, and which is limited by technology and/or costs. The development of the concept of analytical goals is leading to a more logical approach to the definition of the term 'acceptable' for each analyte, and we can at least pride ourselves on knowing which assays currently fall below 'acceptable' performance, and the reasons why.
In general, our analytical performance in the UK gives some grounds for satisfaction, but it must be remembered that the production of a 'correct' analytical result is only part of the process which occurs between the taking of a sample and the issue of the report. The areas of specimen mix-up, at the ward and at reception, have been studied, as have specimen switching within the laboratory and transcription errors (now hopefully reduced in frequency by the advent of computerised reporting systems).
There remains the whole area of the checking and interpretation of the final report form, an area in which clinical biochemists claim both a special expertise and an important role in the provision of a laboratory service. But do we in fact perform this role, and if so how well do we do?
Here, for almost the first time, we come into the realm of subjectivity, not only concerning qualitative assessment such as the interpretation of electrophoretic patterns and thin-layer chromatograms, but also in weighing the import of quantitative results, either singly or as dynamic function tests.
There are two extremes of view on this point.
One claims that interpretation of the significance of a test is the function of the clinician who is in possession of all the facts concerning the patient. Those holding this view believe that the clinical biochemist, who has before him or her only a set or series of laboratory results and minimal clinical information, has no role to play in commenting on the result. Such a view can only be detrimental to the role of medically qualified clinical biochemists. The alternative extreme, that laboratory results should not be issued without scrutiny, has considerable appeal provided that sufficient staff are available, but is sometimes not honoured at inconvenient times out of hours. Where staff are short, errors may occur due to the sheer numbers of reports which have to be scrutinised at peak periods (lunchtime and 4-5 pm).
Exception reporting, in which only reports containing first-time results---or showing a significant change from a previous recent reportare scrutinised, is one method of lowering the workload to manageable proportions in order to allow meaningful discussion, either verbally or in writing, between laboratory and ward. The problem is how to set the limits and how to organise the separation of reports into 'automatic' issues and those which require comment or action.
In order to implement any objective, middleof-the-road approach to the interpretation of reports, it is necessary to define some guidelines for a procedure which is in essence subjective.
The subject overlaps into the worrying area of medical audit; yet it has been addressed by our colleagues in histopathology who have been prepared to circulate 'spot' slides for comment on a national scale.
The question of quality control of the interpretative side of our subject has been ducked for many years. The paper by Wiener;' discussing the advice given on the non-analytical aspects of glucose tolerance testing and the interpretation of simple results based upon known WHO guidelines, gives rise to a degree of misgiving. Similar unpublished surveys in the endocrine field suggest that all is not well here either. This is not to say that the interpretations given by clinical chemists are inferior to those of their colleagues in other clinical specialties; but it does suggest that there is an area here that is worthy of further investigation. Should we and could we test the quality of our interpretative ability as a profession? My view is that we should, but have we the courage of our convictions?
